Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs - Walter, MF; Jacob, RF; Day, CA (Atherosclerosis, 2004)
et al.